Gestational Diabetes and Infant Growth
Author Information
Author(s): Emily M. Nagel, Armando Peña, Jonathan M. Dreyfuss, Eric F. Lock, Kelsey E. Johnson, Chang Lu, David A. Fields, Ellen W. Demerath, Elvira Isganaitis
Primary Institution: University of Minnesota
Hypothesis
Does the human milk metabolome differ by gestational diabetes (GD) status in ways that are associated with infant growth and body composition?
Conclusion
Gestational diabetes was associated with differences in human milk metabolites that may beneficially influence infant growth and body composition.
Supporting Evidence
- GD was associated with differential levels of 9 metabolites of 458 tested.
- 3 metabolites were higher and 6 were lower in women with GD.
- Phenylacetic acid was associated with length for age z score.
- 2-hydroxybutyric acid was negatively associated with percentage body fat.
- Stearoylcarnitine was associated with greater odds of rapid weight gain.
- GD was associated with greater length for age z scores.
Takeaway
Moms with gestational diabetes have different milk that might help their babies grow better and stay healthy.
Methodology
Cohort study analyzing human milk metabolome and infant growth metrics.
Potential Biases
Potential bias due to the use of older diagnostic criteria for gestational diabetes.
Limitations
The study's findings may not be generalizable due to the predominantly White and highly educated sample.
Participant Demographics
348 mother-infant dyads, predominantly breastfeeding, with 53 diagnosed with GD; mostly White, educated, and from upper to middle-class backgrounds.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI, 0.02 to 0.16
Statistical Significance
FDR<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website